[1] |
朱方玉,漆洪波. 2018 FIGO胎盘植入性疾病指南解读 [J]. 中国实用妇科与产科杂志,2018, 34(12): 1353-1359.
|
[2] |
Jauniaux E, Ayres-De-Campos D. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction [J]. Int J Gynaecol Obstet, 2018, 140(3): 261-264.
|
[3] |
Silver RM, Branch DW. Placenta Accreta Spectrum [J]. N Engl J Med, 2018, 378(16): 1529-1536.
|
[4] |
中华医学会妇产科学分会产科学组. 胎盘植入诊治指南(2015) [J]. 中华围产医学杂志,2015, 18(7): 481-485.
|
[5] |
谢幸,孔北华,段涛. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018:84,89.95,107,135,141,148-149,205-206,220-221.
|
[6] |
Farquhar CM, Li Z, Lensen S, et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case-control study [J]. BMJ Open, 2017, 7(10): e017713.
|
[7] |
Carusi DA. The Placenta Accreta Spectrum, Epidemiology and Risk Factors [J]. Clin Obstet Gynecol, 2018, 61(4): 733-742.
|
[8] |
Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries [J]. BJOG, 2016, 123(8): 1348-1355.
|
[9] |
Kaser DJ, Melamed A, Bormann CL, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accrete [J]. Fertil Steril, 2015, 103(5): 1176-1184.
|
[10] |
Ishishara O, Araki R, Kuwahara A, et al. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan [J]. Fertil Steril, 2014, 101(1): 128-133.
|
[11] |
Antonia I, Marco L, Asma K, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis [J]. J Matern Fetal Neonatal Med, 2018, 22: 1-11.
|
[12] |
Belfort MA. Indicated preterm birth for placenta accrete [J]. Semin Perinatol, 2011, 35(5): 252-256.
|
[13] |
Vinograd A, Wainstock T, Mazor M, et al. Placenta accreta is an independent risk factor for late pre-term birth and perinatal mortality [J]. J Matern Fetal Neonatal Med, 2015, 28(12): 1381-1387.
|
[14] |
Azar M, Hutcheon JA, Shiliang L, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage [J]. Obstet Gynecol, 2015, 125(4): 814-821.
|
[15] |
Nyfløt LT, Sandven I, Stray-Pedersen B, et al. Risk factors for severe postpartum hemorrhage: a case-control study [J]. BMC Pregnancy and Childbirth, 2017, 17(1): 17.
|
[16] |
Ruiter-Ligeti J, Vincent S, Czuzoj-Shulman N, et al. Risk Factors, Incidence, and Morbidity Associated With Obstetric Clostridium difficile Infection [J]. Obstet Gynecol, 2018, 131(2): 387-391.
|
[17] |
Samuel W, Mehretu B, Samson G. Magnitude and factors associated with post-cesarean surgical site infection at Hawassa University Teaching and referral hospital, southern Ethiopia: a cross-sectional study [J]. Ethiop J Health Sci, 2017, 27(3): 283-286.
|
[18] |
Ying H, Lu Y, Dong YN, et al. Effect of Placenta Previa on Preeclampsia [J]. Plos One, 2016, 11(1): e0146126.
|